Monkeypox is less deadly than smallpox, with a mortality rate below 4 per cent, but experts are worried about the unusual spread of the disease beyond Africa where it usually circulates
The Centre on Friday issued an alert to the National Centre for Disease Control (NCDC) and the Indian Council of Medical Research (ICMR) and asked them to keep a close watch on the situation evolving
Health experts have reportedly said that Monkeypox patients could pass on the disease for up to four weeks after symptoms appear.
The research has reviewed hundreds of potential cases from the last 20 years, which only amounted to 21 children with a definite diagnosis
Over 1,000 cases of dengue have been reported in the national capital this year, with more than 280 fresh cases logged in the last one week, according to a civic report released on Monday. Of the total count of dengue cases recorded in Delhi this season, 665 have been recorded this month till October 23. Cases of the vector-borne disease have been rising in the city in the last two weeks, and the first death due to it in Delhi was recorded on October 18. The deceased was identified as Mamta Kashyap, aged about 35, and was a resident of Sarita Vihar in south Delhi. She died of dengue late September at a private hospital here. According to the civic report on vector-borne diseases released on Monday, one death due to dengue and a total of 1,006 dengue cases have been recorded this season till October 23, which is the highest cases count since 2018 for the same period. The total number of cases this year till October 16 had stood at 723. So, 283 fresh cases have been logged in one ..
Firozabad's Chief Medical Officer Neeta Kulshresth was removed on Wednesday following the spate of deaths
The drug is used in the treatment of Mucormycosis (black fungus)
Known as biosafety level 4 (BSL4) labs, these are designed and built so that researchers can safely work with the most dangerous pathogens on the planet ones that can cause serious disease
Union Minister for Chemicals and Fertilisers DV Sadananda Gowda on Monday said that 1,06,300 vials of black fungus drugs Amphotericin B have been allocated to states, union territories and to the Central Institutions."Ensuring significant availability of Liposomal #Amphotericin B, additional 106300 vials of the drug have been allocated across all the States/UTs and Central Institutions today," Sadananda Gowda said in a tweet.The Minister said that a total of 53,000 vials of Conventional Amphotericin B have also been allocated to all the states, UTs and Central Institutions today."A total of 53,000 vials of Conventional #Amphotericin B have also been allocated to all the States/UTs & Central Institutions today. The allocation of #ConventionalAmphotericin B is being made to ensure its smooth supply and timely treatment of patients," he said in another tweet.He further said that additional 9,400 vials of Liposomal Amphotericin B and 4,680 vials of Conventional Amphotericin B have ..
The government has allocated an additional 1.7 lakh vials of Amphotericin-B drug, used to treat black fungus infection, to states and union territories, Union Minister Sadananda Gowda said on Wednesday. "Ensuring adequate availability and smooth supply of #Amphotericin-B across the country, additional 1,70,000 vials of the drug have been allocated to all the States/UTs & Central Institutions today," the chemicals and fertilisers minister tweeted. Gowda added that an additional 15,520 vials of the critical drug have been allocated to Karnataka. "So far, a total of 40,470 vials of the drug have been allocated to the state including today's allocation for timely treatment of patients," he said. Amphotericin-B is used to treat Mucormycosis, also known as black fungus, which damages the nose, eyes, sinuses, and sometimes even the brain. Mucormycosis can be life-threatening in diabetic or severely immuno-compromised individuals such as cancer patients or people with HIV/AIDS. The ...
Karnataka has reported 1,784 cases of mucormycosis or black fungus while 62 have recovered and 111 have died, said State Health Minister Dr K Sudhakar on Saturday.
The Maharashtra government on Friday capped the charges for treatment of mucormycosis patients at private hospitals in the state, where the official number of such cases has gone above 5,000.
The Bombay High Court on Thursday said that Maharashtra needs to tell the Centre that mucormycosis patients in the Marathwada region of the state are dying due to the shortage of medicine required in its treatment. Justices R V Ghuge and B U Debadwar of the high court's Aurangabad bench was informedthat patients in Marathwada were being under-treated as there is a shortage in the supply of Amphotericin B, a drug used in the treatment of mucormycosis or black fungus infection. The bench was hearing petitions pertaining to the COVID-19 pandemic. Advocate Satyajit Bora, appointed to assist the court, argued that patients are being administered one to two injections per day as against the requirement of four to five injections per patient per day. As a consequence, there have been 124 deaths. Even today, there is a shortage of about 70 per cent of the required quantity of the drug, he said. Government pleader D R Kale told the court that currently there are 1,178 ...
Meanwhile, the country extended the lockdown in the Kathmandu Valley till June 14 due to the spike in COVID-19 cases.
Of the 1,250 affected patients, 1,193 are still under treatment.
He said an additional 1,930 vials of Amphotericin-B has been allocated to Karnataka.
: Researchers at Indian Institute of Technology, Hyderabad, have developed an oral solution to treat Black Fungus (Mucormycosis) and other fungus and are ready to transfer the technology to take it forward, the premier institute said.
About 600 cases of black fungus or mucormycosis have been reported here till May 26
The Delhi High Court Thursday allowed duty free import of Amphotericin B